Inactief instrument

Andere talen U.S. Stem Cell, Inc. Other OTC

Aandelen

U.S. Stem Cell, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	14-04-23
U.S. Stem Cell, Inc. Auditor Raises 'Going Concern' Doubt	14-04-23
U.S. Stem Cell, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	09-11-22
U.S. Stem Cell, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	23-05-22
U.S. Stem Cell, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	31-03-22
U.S. Stem Cell, Inc. Auditor Raises 'Going Concern' Doubt	31-03-22
U.S. Stem Cell, Inc. Announces Management Changes	09-03-22
U.S. Stem Cell, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	09-11-21
U.S. Stem Cell, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	12-08-21
U.S. Stem Cell, Inc. Provides Revenue Guidance for the Full Year 2017	06-02-18

Geen resultaten voor deze zoekopdracht